Prognostic factor analysis from EORTC trials in advanced prostatic cancer. EORTC-GU Group.
de Voogt
H J
HJ
Dpt. of Urology, Free University Hospital, Amsterdam.
Suciu
S
S
Sylvester
R
R
Pavone-Macaluso
M
M
Smith
P H
PH
de Pauw
M
M
D000135:Acid Phosphatase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004961:Estramustine / Q000008:administration & dosage; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D000970:Antineoplastic Agents; D006728:Hormones; D004961:Estramustine; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase